Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S E Franck
Pegvisomant in Combination With Long-Acting Somatostatin Analogues in Acromegaly: The Role of the GH Receptor Deletion of Exon 3
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Prescription Patterns of Long-Acting Somatostatin Analogues
SAGE Open Medicine
Medicine
Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant
Journal of Clinical Endocrinology and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes
Medical Treatment With Somatostatin Analogues in Acromegaly: Position Statement
The Korean Journal of Medicine
Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly
Journal of Endocrinological Investigation
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness of Somatostatin Analogues for the Treatment of Acromegaly in Colombia
Open Journal of Endocrine and Metabolic Diseases
Combined Treatment for Acromegaly With Long-Acting Somatostatin Analogs and Pegvisomant: Long-Term Safety for Up to 4.5 Years (Median 2.2 Years) of Follow-Up in 86 Patients
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Interpreting Biochemical Control Response Rates With First-Generation Somatostatin Analogues in Acromegaly
Pituitary
Endocrinology
Metabolism
Diabetes
